Device Trial Radar · NCT04858126
Accuracy of ECOM Plus Versus Pulmonary Artery Catheter
Last checked: Nov 20, 2026Latest source record: Feb 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
110
Actual
Start
Jan 1, 2021
Primary completion
Sep 11, 2023
Study completion Sep 11, 2023
Sponsor
- Lead sponsor
- ECOM Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 26, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Study will compare the accuracy of the ECOM Plus Endotracheal Cardiac Output Monitor (ECOM) without the use of the arterial pressure waveform from the arterial line to 1) the current clinical standard of cardiac output measured by intermittent room temperature bolus thermodilution using a PAC, 2) the current ECOM System with the use of the arterial blood pressure waveform from a radial arterial line and 3) the Flo-Trac® System.
Conditions
- Hemodynamic Monitoring
Interventions
ECOM cardiac outputDevice
Measure cardiac output during perioperative period and compare to pulmonary artery catheter thermal dilution cardiac output measurement.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of ECOM Plus impedance and thermal dilution cardiac output measurementsTime frame: 6 months.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
VA San Francisco
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.